Status:

RECRUITING

Precision Exercise in Children With Malignant Hemopathies

Lead Sponsor:

University of Milano Bicocca

Collaborating Sponsors:

Comitato Maria Letizia Verga,Italy

Conditions:

Leukemia, Myeloid, Acute

Leukemia, B-cell

Eligibility:

All Genders

2-18 years

Phase:

NA

Brief Summary

In the early years of life and during adolescence, physical activity is crucial for good development of motor skills. It is even more so for those children and young people who are forced to undergo a...

Detailed Description

State of the art. Today, thanks to the progress made in the early diagnosis and treatment of cancer, there are more than 300 thousand young patients in Europe who have been cured of pediatric cancer, ...

Eligibility Criteria

Inclusion

  • Children with malignant hemopathies attending the Maria Letizia Verga Center

Exclusion

  • Children under 2 years

Key Trial Info

Start Date :

April 3 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 3 2026

Estimated Enrollment :

380 Patients enrolled

Trial Details

Trial ID

NCT04090268

Start Date

April 3 2017

End Date

April 3 2026

Last Update

January 2 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maria Letizia Verga Center, Pediatric Clinic, University of Milan Bicocca, at the Foundation for the Mother and Her Child

Monza, MB, Italy, 20900

Precision Exercise in Children With Malignant Hemopathies | DecenTrialz